STATE STREET CORP - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 48 filers reported holding EVELO BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$27,490
-94.4%
152,129
-50.0%
0.00%
Q4 2022$489,856
+105.8%
304,258
+167.2%
0.00%
Q3 2022$238,000
+19.6%
113,858
+20.9%
0.00%
Q2 2022$199,000
-89.9%
94,158
-83.7%
0.00%
Q1 2022$1,962,000
-42.3%
578,861
+3.3%
0.00%
Q4 2021$3,402,000
-10.2%
560,392
+4.1%
0.00%
Q3 2021$3,790,000
-43.7%
538,343
+9.9%
0.00%
Q2 2021$6,730,000
+95.6%
489,781
+52.3%
0.00%
Q1 2021$3,440,000
-3.3%
321,518
+9.2%
0.00%
Q4 2020$3,559,000
+157.9%
294,360
+12.4%
0.00%
Q3 2020$1,380,000
+22.1%
261,794
+13.5%
0.00%
Q2 2020$1,130,000
+30.8%
230,607
+0.3%
0.00%
Q1 2020$864,000
-7.1%
229,985
+0.4%
0.00%
Q4 2019$930,000
-31.2%
228,980
+3.4%
0.00%
Q3 2019$1,351,000
-32.0%
221,452
+0.1%
0.00%
Q2 2019$1,986,000
+21.2%
221,192
+8.0%
0.00%
Q1 2019$1,639,000
-24.6%
204,883
+22.6%
0.00%
Q4 2018$2,174,000
+85.7%
167,087
+73.9%
0.00%
Q3 2018$1,171,000
+131.9%
96,085
+124.5%
0.00%
Q2 2018$505,00042,8000.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders